Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (101-110 of 285) with videos related to

Pageof 29
Sort By:
Analytical Chemistry|April 7, 2011
Monoclonal antibody cocktail as an enrichment tool for acetylome analysisPatrick G Shaw, Raghothama Chaerkady, Zhen Zhang, et al.
Breast Cancer Research and Treatment|April 1, 2011
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cellsYi Huang, Shauna N Vasilatos, Lamia Boric, et al.
Molecular Cancer Research : MCR|May 29, 2008
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cellsQun Zhou, Agoston T Agoston, Peter Atadja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
P7 antigen expression in human breast cancerXiaowei Yang, Susan Groshen, Silvia C Formenti, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2005
Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cellsDipali Sharma, Julie Blum, Xiaowei Yang, et al.
Bioorganic & Medicinal Chemistry|January 26, 2006
Anticancer activities of novel chalcone and bis-chalcone derivativesAneta Modzelewska, Catherine Pettit, Geetha Achanta, et al.
Breast Cancer Research and Treatment|July 13, 2010
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancerYuan Yao, Angela M H Brodie, Nancy E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim supportAntonio C Wolff, Richard J Jones, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|June 19, 2012
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancerJoseph A Sparano, Lori J Goldstein, Nancy E Davidson, et al.
Carcinogenesis|January 29, 2013
Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cellsShauna N Vasilatos, Tiffany A Katz, Steffi Oesterreich, et al.
Pageof 29

Showing results (101-110 of 285) with videos related to

Sort By:
Pageof 29
Analytical Chemistry|April 7, 2011
Monoclonal antibody cocktail as an enrichment tool for acetylome analysisPatrick G Shaw, Raghothama Chaerkady, Zhen Zhang, et al.
Breast Cancer Research and Treatment|April 1, 2011
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cellsYi Huang, Shauna N Vasilatos, Lamia Boric, et al.
Molecular Cancer Research : MCR|May 29, 2008
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cellsQun Zhou, Agoston T Agoston, Peter Atadja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
P7 antigen expression in human breast cancerXiaowei Yang, Susan Groshen, Silvia C Formenti, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2005
Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cellsDipali Sharma, Julie Blum, Xiaowei Yang, et al.
Bioorganic & Medicinal Chemistry|January 26, 2006
Anticancer activities of novel chalcone and bis-chalcone derivativesAneta Modzelewska, Catherine Pettit, Geetha Achanta, et al.
Breast Cancer Research and Treatment|July 13, 2010
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancerYuan Yao, Angela M H Brodie, Nancy E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim supportAntonio C Wolff, Richard J Jones, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|June 19, 2012
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancerJoseph A Sparano, Lori J Goldstein, Nancy E Davidson, et al.
Carcinogenesis|January 29, 2013
Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cellsShauna N Vasilatos, Tiffany A Katz, Steffi Oesterreich, et al.
Pageof 29